Immunotherapy

January 5, 2023

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
September 26, 2022

Now Enrolling: The EA2205 research study is testing a new treatment approach for a rare form of liver cancer

Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer